Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Apex Graphics | Contract Pharma

What are you searching for?

Sign in

Search by

Apex Graphics

Apex Graphics

Company Headquarters

320 Ambassador Drive , Mississauga, ON, L5T 2J3, CA

Driving Directions Phone: View Phone Fax: View Fax
View website

Company Description

Apex Graphics provides solutions to your most difficult secondary packaging problems. We specialize in printing inserts, outserts, IFUs, booklets, multi-component bundled literature, med guides, pads, and marketing PIs. We also offer complete commercial printing services to support our customers' marketing and sales department needs.

Request more information from Apex Graphics

Request more information from Apex Graphics

Categories from Apex Graphics

Animal Health
Packaging, Development
Packaging, Labels
Supplier, Secondary Packaging Materials

Related Content

Thermo Fisher Scientific

Breaking News

Thermo Fisher Introduces M Series Centrifuges 

Designed to deliver precise performance in a compact footprint to support clinical, pharma research and research labs. 

By: Kristin Brooks

Collaborations & Alliances

ProBioGen, Zag Bio Partner to Accelerate Thymus-Targeted Bifunctional Antibody Program

ProBioGen to provide cell line development, process development, and GMP manufacturing for Zag Bio's lead ZAG-101 product candidate.

By: Charlie Sternberg

Collaborations & Alliances

Wheeler Bio Licenses ATUM’s miFuc Platform for Afucosylated Antibodies

Provides clients with more options for their pharmaceutical development.

Breaking News

Coriolis Pharma Adds Analytical Ultracentrifugation to Its Service Offerings

Expands its existing portfolio of GMP methods for the development of drug products.

Breaking News

Basilea Acquires Broad Spectrum Antifungal Fosmanogepix

Acquisition adds promising drug candidate to Basilea’s late-stage clinical antifungal pipeline.

Breaking News

Basilea Acquires Antifungal for Aspergillus Mold Infections

First-in-class antifungal has demonstrated fungicidal activity against clinically important molds such as Aspergillus.

Features

The Developability Challenges with Bifunctional Targeted Protein Degraders

Exploring the challenges and opportunities with targeted protein degradation.

Promotions & Moves

Ubiquigent Names Rishi Shah Head of Chemistry

Shah brings extensive heterobifunctional and chemical biology expertise to drive internal DUBTAC drug discovery and DUB-focused partnerships.

Breaking News

Schreinger MediPharm Unveils Multifunctional Security Label for Prefilled Syringes

Syringe-Closure-Wrap security label provides clear first-opening indication, and value-added functions and features.

Breaking News

BARDA Invests in Development of Antifungal Treatments

Seeks partnerships to develop broad-spectrum next-generation antifungal drugs to treat high-priority fungal infections.

Breaking News

Thermo Fisher Scientific Launches DynaSpin Single-Use Centrifuge System

Designed to provide an optimal single-use solution for large-scale cell culture harvesting.

Breaking News

Pfizer Acquires Amplyx Pharmaceuticals

Deal expands anti-infectives pipeline with addition of novel antifungal Phase 2 candidate, Fosmanogepix (APX001).

Breaking News

NMPA Accepts Application for Clinical Trial of Bifunctional Fusion Protein

JS201, developed by Junshi Biosciences, can simultaneously target PD-1 and TGF-β.

Breaking News

Schreiner MediPharm Introduces Multifunctional Covert-Hologram Seal

Seal features an irreversible, holographic effect, and complies with the Falsified Medicines Directive

Collaborations & Alliances

Basilea Forms Partnership in Japan with Asahi Kasei

Grants exclusive license to develop and commercialize antifungal isavuconazole